Herbicide use in farming and other jobs in relation to non-Hodgkin's lymphoma (NHL) risk.


Journal

Occupational and environmental medicine
ISSN: 1470-7926
Titre abrégé: Occup Environ Med
Pays: England
ID NLM: 9422759

Informations de publication

Date de publication:
12 2022
Historique:
received: 27 03 2022
accepted: 12 09 2022
pubmed: 8 10 2022
medline: 19 11 2022
entrez: 7 10 2022
Statut: ppublish

Résumé

Given mixed evidence for carcinogenicity of current-use herbicides, we studied the relationship between occupational herbicide use and risk of non-Hodgkin's lymphoma (NHL) in a large, pooled study. We pooled data from 10 case-control studies participating in the International Lymphoma Epidemiology Consortium, including 9229 cases and 9626 controls from North America, the European Union and Australia. Herbicide use was coded from self-report or by expert assessment in the individual studies, for herbicide groups (eg, phenoxy herbicides) and active ingredients (eg, 2,4-dichlorophenoxyacetic acid (2,4-D), glyphosate). The association between each herbicide and NHL risk was estimated using logistic regression to produce ORs and 95% CIs, with adjustment for sociodemographic factors, farming and other pesticides. We found no substantial association of all NHL risk with ever-use of any herbicide (OR=1.10, 95% CI: 0.94 to 1.29), nor with herbicide groups or active ingredients. Elevations in risk were observed for NHL subtypes with longer duration of phenoxy herbicide use, such as for any phenoxy herbicide with multiple myeloma (>25.5 years, OR=1.78, 95% CI: 0.74 to 4.27), 2,4-D with diffuse large B-cell lymphoma (>25.5 years, OR=1.47, 95% CI: 0.67 to 3.21) and other (non-2,4-D) phenoxy herbicides with T-cell lymphoma (>6 years, lagged 10 years, OR=3.24, 95% CI: 1.03 to 10.2). An association between glyphosate and follicular lymphoma (lagged 10 years: OR=1.48, 95% CI: 0.98 to 2.25) was fairly consistent across analyses. Most of the herbicides examined were not associated with NHL risk. However, associations of phenoxy herbicides and glyphosate with particular NHL subtypes underscore the importance of estimating subtype-specific risks.

Identifiants

pubmed: 36207110
pii: oemed-2022-108371
doi: 10.1136/oemed-2022-108371
pmc: PMC9669193
mid: NIHMS1842503
doi:

Substances chimiques

Herbicides 0
Pesticides 0

Types de publication

Journal Article Research Support, N.I.H., Extramural

Langues

eng

Sous-ensembles de citation

IM

Pagination

795-806

Subventions

Organisme : NCI NIH HHS
ID : P30 CA015083
Pays : United States
Organisme : NCI NIH HHS
ID : P50 CA097274
Pays : United States
Organisme : NCI NIH HHS
ID : R01 CA092153
Pays : United States
Organisme : NCI NIH HHS
ID : R03 CA199515
Pays : United States

Informations de copyright

© Author(s) (or their employer(s)) 2022. Re-use permitted under CC BY-NC. No commercial re-use. See rights and permissions. Published by BMJ.

Déclaration de conflit d'intérêts

Competing interests: None declared.

Références

J Natl Cancer Inst. 2018 May 1;110(5):509-516
pubmed: 29136183
Mutat Res Rev Mutat Res. 2019 Jul - Sep;781:186-206
pubmed: 31342895
Cancer Causes Control. 2014 Sep;25(9):1233-7
pubmed: 24981100
Ann Oncol. 1998;9 Suppl 5:S25-30
pubmed: 9926234
Int J Cancer. 2021 Nov 15;149(10):1768-1786
pubmed: 34270795
Int J Mol Epidemiol Genet. 2011;2(2):95-113
pubmed: 21686124
Ann N Y Acad Sci. 2006 Sep;1076:366-77
pubmed: 17119216
Environ Health Perspect. 2016 Apr;124(4):396-405
pubmed: 26340796
Blood. 2010 Nov 18;116(20):e90-8
pubmed: 20699439
Lancet Oncol. 2015 May;16(5):490-1
pubmed: 25801782
Ann Epidemiol. 2017 Apr;27(4):281-289.e4
pubmed: 28476329
Cancer Causes Control. 2019 Apr;30(4):311-322
pubmed: 30805813
Occup Environ Med. 2002 Sep;59(9):575-93; discussion 594
pubmed: 12205230
Am J Ind Med. 2003 Dec;44(6):576-83
pubmed: 14635234
Occup Environ Med. 2009 May;66(5):291-8
pubmed: 19017688
Occup Environ Med. 2009 Jan;66(1):68-70
pubmed: 18805876
Cancer Res. 1992 Oct 1;52(19 Suppl):5510s-5515s
pubmed: 1394165
Environ Sci Eur. 2016;28(1):3
pubmed: 27752438
Am J Epidemiol. 2005 Nov 1;162(9):849-57
pubmed: 16177143
Am J Ind Med. 2003 Dec;44(6):627-36
pubmed: 14635239
Environ Health. 2021 Apr 28;20(1):49
pubmed: 33910586
Scand J Work Environ Health. 2019 Nov 1;45(6):600-609
pubmed: 31246262
Am J Epidemiol. 2004 Jan 15;159(2):148-54
pubmed: 14718216
Occup Environ Med. 2013 Feb;70(2):91-8
pubmed: 23117219
Cancer Epidemiol Biomarkers Prev. 2005 Apr;14(4):934-7
pubmed: 15824166
J Occup Environ Med. 2018 Oct;60(10):911-916
pubmed: 30289833
Environ Health. 2012 Jun 12;11:39
pubmed: 22691464
J Natl Cancer Inst Monogr. 2014 Aug;2014(48):1-14
pubmed: 25174022
Lancet Oncol. 2015 Aug;16(8):891-2
pubmed: 26111929
Ann Epidemiol. 2017 Apr;27(4):290-292.e5
pubmed: 28292638
Int J Epidemiol. 2019 Oct 1;48(5):1519-1535
pubmed: 30880337

Auteurs

Anneclaire J De Roos (AJ)

Department of Environmental and Occupational Health, Dornsife School of Public Health, Drexel University, Philadelphia, Pennsylvania, USA aderoos@drexel.edu.

Lin Fritschi (L)

School of Population Health, Curtin University, Perth, Western Australia, Australia.

Mary H Ward (MH)

Occupational and Environmental Epidemiology Branch, Division of Cancer Epidemiology and Genetics, National Cancer Institute, National Institutes of Health, Bethesda, Maryland, USA.

Alain Monnereau (A)

Registre des Hémopathies Malignes de la Gironde, Institut Bergonié, University of Bordeaux, Bordeaux, France.
Epidemiology of Childhood and Adolescent Cancers Group, Center of Research in Epidemiology and Statistics Sorbonne Paris Cité (CRESS), INSERM, Paris, France.

Jonathan Hofmann (J)

Occupational and Environmental Epidemiology Branch, Division of Cancer Epidemiology and Genetics, National Cancer Institute, National Institutes of Health, Bethesda, Maryland, USA.

Leslie Bernstein (L)

Division of Biomarkers of Early Detection and Prevention, Beckman Research Institute of City of Hope, City of Hope Comprehensive Cancer Center, Duarte, California, USA.

Parveen Bhatti (P)

Cancer Control Research, BC Cancer, Vancouver, British Columbia, Canada.

Yolanda Benavente Moreno (Y)

Cancer Epidemiology Research Program, Institut Català d'Oncologia (ICO)/Institut d'Investigació Biomèdica de Bellvitge (IDIBELL), L'Hospitalet de Llobregat, Barcelona, Spain.
Centro de Investigación Biomédica en Red: Epidemiología y Salud Pública (CIBERESP), Instituto de Salud Carlos III, Madrid, Spain.

Geza Benke (G)

Department of Epidemiology and Preventive Medicine, School of Public Health and Preventive Medicine, Monash University, Melbourne, Victoria, Australia.

Delphine Casabonne (D)

Cancer Epidemiology Research Program, Institut Català d'Oncologia (ICO)/Institut d'Investigació Biomèdica de Bellvitge (IDIBELL), L'Hospitalet de Llobregat, Barcelona, Spain.
Centro de Investigación Biomédica en Red: Epidemiología y Salud Pública (CIBERESP), Instituto de Salud Carlos III, Madrid, Spain.

Jacqueline Clavel (J)

Epidemiology of Childhood and Adolescent Cancers Group, Center of Research in Epidemiology and Statistics Sorbonne Paris Cité (CRESS), INSERM, Paris, France.

Pierluigi Cocco (P)

Centre for Occupational and Environmental Health, Division of Population Health, University of Manchester, Manchester, UK.
Department of Medical Sciences and Public Health, University of Cagliari, Cagliari, Italy.

Tran Huynh (T)

Department of Environmental and Occupational Health, Dornsife School of Public Health, Drexel University, Philadelphia, Pennsylvania, USA.

Andrea 't Mannetje (A)

Centre for Public Health Research, Massey University, Wellington, New Zealand.

Lucia Miligi (L)

Environmental and Occupational Epidemiology Branch, Institute for Cancer Research, Prevention and Clinical Network (ISPRO), Florence, Italy.

Sara Piro (S)

Environmental and Occupational Epidemiology Branch, Institute for Cancer Research, Prevention and Clinical Network (ISPRO), Florence, Italy.

Nathaniel Rothman (N)

Occupational and Environmental Epidemiology Branch, Division of Cancer Epidemiology and Genetics, National Cancer Institute, National Institutes of Health, Bethesda, Maryland, USA.

Leah H Schinasi (LH)

Department of Environmental and Occupational Health, Dornsife School of Public Health, Drexel University, Philadelphia, Pennsylvania, USA.

Claire M Vajdic (CM)

The Kirby Institute, University of New South Wales, Kensington, New South Wales, Australia.

Sophia S Wang (SS)

Division of Health Analytics, Department of Computational and Quantitative Medicine, City of Hope Comprehensive Cancer Center, Duarte, California, USA.

Yawei Zhang (Y)

National Cancer Center/National Clinical Research Center for Cancer/Cancer Hospital, Chinese Academy of Medical Sciences and Peking Union Medical College, Beijing, China.

Susan L Slager (SL)

Department of Quantitative Health Sciences, Division of Computational Biology, Mayo Clinic, Rochester, Minnesota, USA.
Department of Medicine, Division of Hematology, Mayo Clinic, Rochester, Minnesota, USA.

James R Cerhan (JR)

Division of Epidemiology, Department of Quantitative Health Sciences, Mayo Clinic College of Medicine, Rochester, Minnesota, USA.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH